CHU Amiens
Amiens, France
NCT Number: NCT03629834
Presently, there isn't any international recommendation to evaluate vigilance in Obstructive Sleep Apnea Syndrome. The French Society of Sleep Research and Medicine (SFRMS) recommend evaluating professional driver with a MWT but no recommendation exists for other patients. After a minimal treatment of 4 weeks, the physician has to evaluate the drowsiness risk of these patients using either an objective test like the MWT or a subjective one. In the university hospital Amiens-Picardie, since the 01/01/2015, every patient with an Obstructive Sleep Apnea Syndrome diagnosed by a polysomnography or a ventilatory polygraphy had a MWT after 4 weeks of treatment. At each time of the evaluation, Epworth Sleepiness Scale, tiredness score of Pichot, and depressive score of Beck are performed.
Looking for future studies?
Notify Me18 year–60 year
All sexes
Observational
Amiens, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Maintenance Wakefulness Test
Time frame: one day
Three levels of vigilance are defined by the MWT : more than 34 min is rated as good vigilance; ≥ 20 et < 34 min as intermediate vigilance; under 20 min as bad vigilance.
Time frame: one day
Two levels of vigilance are defined by the ESS score: score ≥11: bad vigilance, <11: good vigilance
Centre Hospitalier Universitaire, Amiens
Other
Internal and Predictive Validity of Epworth Sleepiness Scale to Evaluate Vigilance of Patient Treated for Obstructive Sleep Apnea Syndrome
Acronym: SAHOS-TIME
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05049928
Apnea, Dyssomnias
Montpellier, France
View Trial DetailsNCT06536894
Apnea, Dyssomnias
Kırşehir, Turkey (Türkiye)
View Trial DetailsNCT03979001
Apnea, Dyssomnias
Dijon, France
View Trial DetailsNCT06581588
Apnea, Dyssomnias
Beijing, Beijing Municipality, China
View Trial Details